| Rutgers University has won
approval for its first new degree in a decade—a Masters of Engineering
in Pharmaceutical Engineering and Science—in an effort pioneered by the
NSF-funded Center for Structured Organic Particulate Systems (CSOPS), an
Engineering Research Center (ERC) based at Rutgers. The degree embodies
the concept of “relevant scholarship,” combining knowledge of the fundamentals
and applications and preparing the students for success in either academia
or industry.
The Center's effort has become
the model for an Engineering-wide professional degree program at Rutgers,
and each department within the Rutgers School of Engineering has now been
directed by Dean Yogesh Jaluria to develop a similar program. The
M.Eng degree won final approval from the New Jersey Presidents Council
in late 2009, and efforts are underway to advertise it to the Center's
industrial members, mentors, and sponsors as well as to pharmaceutical
industry practitioners nationwide, in addition to current students.
The new degree program is
designed to provide graduates with skills and tools to be innovative, competent,
contributing engineers in the pharmaceutical industry, with the ability
to meet the constantly changing needs of industry for state-of-the art
research/manufacturing practices and protocols. The studies include
five Pharmaceutical Engineering Core courses and a list of electives, several
of which were new courses developed, approved, and taught during the 2008/09
academic year.
The degree program is targeted
primarily at full-time industrial employees who would earn their M.Eng
on a part-time basis. For this reason, three-credit-hour Pharmaceutical
Engineering Courses are offered in the evenings. See http://pharmeng.rutgers.edu/acadMoe.html. |
